Alternative regimens of anti-VEGF therapy for neovascular AMD, variable treatment in particular, have become the de facto clinical practice. Their wide adoption is based on a tacit belief in their ...

A recent study published in JAMA Network Open reveals that higher levels of exposure to outdoor artificial light at night can increase the risk of incident exudative age-related macular degeneration.

Exposure to outdoor artificial light at night could be linked to the onset of age-related macular degeneration, a chronic condition that is a leading source of irreversible blindness, South Korean ...

Vaidehi Dedania, MD, discusses how to navigate the initial conversation with patients newly diagnosed with wet age-related macular degeneration, emphasizing the importance of discussing expectations ...

"It is not necessary to measure the extent, height, or length of the DLS [double layer sign]. It is sufficient to know, however, that when DLS is seen that it’s a key risk factor and that regular ...

Patients with a confirmed diagnosis of OSA were compared to a control group without OSA to assess nonadvanced AMD progression. At 5 years, participants with OSA had a significantly higher risk of both ...

Patients using GLP-1 receptor agonists appear to have a lower risk of age-related macular degeneration and primary open-angle glaucoma. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) ...

Age-related macular degeneration (AMD) has a worldwide incidence of between 30 and 50 million people and is expected to affect up to 288 million people by the year 2040. Globally, AMD constitutes 6% ...